NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

980.50a day ago
999.95a day ago
arrow

LOWER/UPPER CIRCUITS

794.20
1,191.30
arrow
Vijaya Diagnostic Cen Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 23.05%, in the last year to ₹699.71 Cr. Its sector's average revenue growth for the last fiscal year was 16.28%.
noteAnnual Net Profit,rose 20.41% in the last year to ₹143.08 Cr. Its sector's average net profit growth for the last fiscal year was 90.14%.
noteQuarterly Revenue,rose 10.17% YoY to ₹207.81 Cr. Its sector's average revenue growth YoY for the quarter was 15.73%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : %

About Vijaya Diagnostic Centre Limited

 

Vijaya Diagnostic Centre Limited operates as India’s biggest B2C-focused integrated diagnostic chain which delivers complete radiology and pathology testing services with a focus on quality and convenience. The Company delivers pathological tests and basic and advanced radiology services and nuclear medicine services through its network of facilities with modern equipment and skilled personnel for fast and precise test results. 

 

The company started its operations in 1981 with ultrasound and echocardiography services in Hyderabad before introducing CT and MRI and nuclear diagnostics and pathology services to create an integrated testing platform in its core markets. Vijaya Diagnostic Centre received its Indian incorporation on June 05, 2002 and maintains its headquarters in Panjagutta Hyderabad while being listed on BSE and NSE stock exchanges. The company achieved public listing status in 2021 before it acquired P.H. Diagnostics in Pune to enter Eastern and Western Indian markets .

 

The network operates through a hub-and-spoke system which expanded to 151 centers throughout 25 cities by the end of FY25. The company operates its business across six geographic areas which include Telangana and Andhra Pradesh and Maharashtra and Karnataka and West Bengal and the National Capital Region. Vijaya has expanded its home collection services and digital booking and payment systems and report access features in addition to its in-centre testing capabilities. The company delivers Corporate Wellness programs to more than 450 multinational corporations operating throughout India  .

 

The Company maintained 3 subsidiaries and 1 step-down subsidiary as of March 31, 2025 which demonstrated its expanding network and back-end operational capabilities.

 

The company achieved four decades of growth starting from 1981 and became a public company in 2021 while entering Kolkata and Pune markets and investing in 3T MRI and 160-slice Cardiac CT technology for enhanced diagnostic capacity and clinical excellence.

 

Vijaya Diagnostic Centre Limited Key Management

 

  • Dr. S. Surendranath Reddy – Executive Chairman
  • S. Suprita Reddy serves as the Managing Director and Chief Executive Officer of the company.
  • K. Sunil Chandra serves as the Executive Director of the company.
  • Ramachandra Reddy S serves as the Chief Financial Officer of the company.
  • Hansraj Singh Rajput holds the position of Company Secretary and Compliance Officer at the organization.

 

Latest Updates on Vijaya Diagnostic Centre Limited

 

  • The company expanded its network to 151 centers which now serve 25 cities throughout India during FY25 while maintaining operations in six different regions  .
  • The company made progress in PH Diagnostics Pune integration and established a new state-of-the-art Vijaya-PH center in Ambegaon while implementing unified operational systems and service standards.
  • The company obtained necessary approvals from stock exchanges and shareholders and creditors to execute the Medinova Diagnostic Services Limited merger which will enhance operational efficiency and network capacity.
  • The company launched two new hub facilities in Ongole and Nizamabad while upgrading the Kurnool Hub with 3T MRI and 160-slice Cardiac CT to increase operational capacity.
  • ESOP allotment: The company distributed 2,90,585 equity shares through the VDCL ESOP Plan 2018 which became available for trading on NSE and BSE during the fiscal year.
  • The company received two major awards during 2025 including Best Healthcare Brand 2025 from ET Now and Best Healthcare Brand 2024 from ET Edge and other industry recognition.
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

VIL delivers wireless and wired telecommunication services that include voice and data and value-added services and enterprise solutions for IoT and cloud and managed services .

The company operates its business across 28 States and 8 Union Territories of India while exports generate 8% of its total revenue .

The company finished a large equity funding process that included an Rs 18,000 crore FPO and executed network deals worth ~Rs 30,000 crore while the Government of India gained 48.99% ownership through spectrum dues conversion .